Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Interleukin-8 Predicts Outcomes for Pediatric Septic Shock

By LabMedica International staff writers
Posted on 27 Aug 2008
Measurement of an immune system protein, interleukin-8 (IL-8) within 24 hours of a child being admitted to a hospital for septic shock has been shown to predict survival.

IL-8 is secreted into the blood as part of the body's immune system response, the chief defense mechanism against infection-related conditions such as septic shock. More...
Previous research has demonstrated that higher blood levels of IL-8 are associated with more severe cases of pediatric septic shock and a greater chance of death. That work also pointed to the potential value of IL-8 as an early diagnostic marker of systemic bacterial infections.

A new study by the same team reported an IL-8 blood level at or below 220 pg/ml should allow doctors to predict with 95% accuracy which of the children with septic shock can survive through conventional antibiotics and therapies for at least 28 days following admission. In addition, measuring IL-8 levels would make it possible to screen lower risk patients out of interventional clinical trials of experimental therapies.

Because the reagents to measure IL-8 are available and blood samples can readily be obtained from patients, Dr. Wong, professor of pediatrics at the University of Cincinnati College of Medicine (OH, USA), is looking to develop a point-of-care test that can be used to detect the IL-8 biomarker in septic shock patients, especially patients being considered for clinical trials.

The study was reported in the August 1, 2008, issue of the American Journal of Respiratory and Critical Care Medicine.

Related Links:
University of Cincinnati College of Medicine



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.